Expert Interview
Discussing treatment options for Biliary Tract Cancer (BTC) and the potential of CTX-009, a bispecific antibody targeting DLL4 and VEGF A, in combination with paclitaxel in patients with advanced BTC
Ticker(s): CMPXInstitution: Fundacion Jimenez Diaz
- Medical Oncologist specializing in gastrointestinal malignancies and neuroendocrine tumors
- Treats ~100 BTC patients annually and is familiar with CTX-009
- Member of the ESMO council, chair of the ESMO Press and Media Affairs Working Group and member of the ESMO Gastrointestinal, Upper digestive Faculty group.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
